packageOritavancin

oritavancin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Oritavancin is a lipoglycopeptide antibiotic used to treat bacterial skin and soft tissue infections such as cellulitis. It is an approved medicine, with one product authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q7102878 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:oritavancin
ATC codes:J01XA05
DrugBank:DB04911
PubChem CID:16136912
ChEBI:82699
Wikidata:Q7102878
formula:C86H97Cl3N10O26
molar mass:1793.12 g/mol (PubChem CID 16136912)
logP:1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown